Fractyl garners $40 mln Series C

Fractyl Laboratories said Thursday that it has secured $40 million in Series C funding. Mithril led the round with participation from General Catalyst, Bessemer Venture Partners and Domain Associates. In conjunction with the funding, Ajay Royan, Mithril's co-founder and managing general partner, has been added to the company's board of directors. Based in Waltham, Mass., Fractyl is a developer of a device-based endoscopic procedure to treat Type 2 diabetes.

North AmericaUSBriefs